In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Scientists at the University of Münster report a major advance in light-powered chemistry for housane molecules on May 20, ...

Tempus AI and Bristol Myers Squibb are expanding their collaboration to apply AI analytics and real world data to oncology and neuroscience drug development. The partnership focuses on using Tempus AI ...

Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.

The proposed federal budget would see drastic cuts made to most of the agencies that fund science. The sheer magnitude of the cuts—including a 40 percent slashing of money going to the National ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate ...

Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research May 19, 2026 4:00 PM ...

However, our U.S. drug development system is slow and dysfunctional. Without systemic fixes, today's promising ALS drugs will ...

Drug discovery remains unevenly distributed worldwide. While many countries in the Global South carry a high burden of infectious, neglected, inflammatory, ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...